Literature DB >> 33622826

Primary Care Relevant Risk Factors for Adverse Outcomes in Patients With COVID-19 Infection: A Systematic Review.

Michelle Bentivegna1, Cassie Hulme1, Mark H Ebell2.   

Abstract

BACKGROUND: The aim of this systematic review is to summarize the best available evidence regarding individual risk factors, simple risk scores, and multivariate models that use patient characteristics, vital signs, comorbidities, and laboratory tests relevant to outpatient and primary care settings.
METHODS: Medline, WHO COVID-19, and MedRxIV databases were searched; studies meeting inclusion criteria were reviewed in parallel, and variables describing study characteristics, study quality, and risk factor data were abstracted. Study quality was assessed using the Quality in Prognostic Studies tool. Random effects meta-analysis of relative risks (categorical variables) and unstandardized mean differences (continuous variables) was performed; multivariate models and clinical prediction rules were summarized qualitatively.
RESULTS: A total of 551 studies were identified and 22 studies were included. The median or mean age ranged from 38 to 68 years. All studies included only inpatients, and mortality rates ranged from 3.2% to 50.5%. Individual risk factors most strongly associated with mortality included increased age, c-reactive protein (CRP), d-dimer, heart rate, respiratory rate, lactate dehydrogenase, and procalcitonin as well as decreased oxygen saturation, the presence of dyspnea, and comorbid coronary heart and chronic kidney disease. Independent predictors of adverse outcomes reported most frequently by multivariate models include increasing age, increased CRP, decreased lymphocyte count, increased lactate dehydrogenase, elevated temperature, and the presence of any comorbidity. Simple risk scores and multivariate models have been proposed but are often complex, and most have not been validated.
CONCLUSIONS: Our systematic review identifies several risk factors for adverse outcomes in COVID-19-infected inpatients that are often available in the outpatient and primary care settings: increasing age, increased CRP or procalcitonin, decreased lymphocyte count, decreased oxygen saturation, dyspnea on presentation, and the presence of comorbidities. Future research to develop clinical prediction models and rules should include these predictors as part of their core data set to develop and validate pragmatic outpatient risk scores. © Copyright 2021 by the American Board of Family Medicine.

Entities:  

Keywords:  C-Reactive Protein; COVID-19; Clinical Prediction Rule; Comorbidity; Meta-Analysis; Prognosis; Risk Factors; Systematic Review

Year:  2021        PMID: 33622826     DOI: 10.3122/jabfm.2021.S1.200429

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  4 in total

1.  Gene Expression Risk Scores for COVID-19 Illness Severity.

Authors:  Derick R Peterson; Andrea M Baran; Soumyaroop Bhattacharya; Angela R Branche; Daniel P Croft; Anthony M Corbett; Edward E Walsh; Ann R Falsey; Thomas J Mariani
Journal:  bioRxiv       Date:  2021-08-24

2.  COVID-19 outcomes among adult patients treated with long-term opioid therapy for chronic non-cancer pain in the USA: a retrospective cohort study.

Authors:  Wen-Jan Tuan; Hannah Spotts; Aleksandra E Zgierska; Robert P Lennon
Journal:  BMJ Open       Date:  2021-11-26       Impact factor: 2.692

3.  Characteristics and outcomes of ambulatory patients with suspected COVID-19 at a respiratory referral center.

Authors:  Vamsi P Guntur; Brian D Modena; Laurie A Manka; Jared J Eddy; Shu-Yi Liao; Nir M Goldstein; Pearlanne Zelarney; Carrie A Horn; Rebecca C Keith; Barry J Make; Irina Petrache; Michael E Wechsler
Journal:  Respir Med       Date:  2022-04-07       Impact factor: 4.582

4.  The risk profile of patients with COVID-19 as predictors of lung lesions severity and mortality-Development and validation of a prediction model.

Authors:  Ezat Rahimi; Mina Shahisavandi; Albert Cid Royo; Mohammad Azizi; Said El Bouhaddani; Naseh Sigari; Miriam Sturkenboom; Fariba Ahmadizar
Journal:  Front Microbiol       Date:  2022-07-25       Impact factor: 6.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.